Emeis Shares Surge 3.11% at Midday Ahead of April 7th Results
Emeis stock significantly advanced this Tuesday at midday, posting a gain of 3.11% to 14.61 euros, after closing the previous day at 14.17 euros. This rebound occurs in a context of a marked recovery of European indices during the session, with the CAC 40 up 2.16% and the DAX 2.22%. The publication of the group's annual 2025 results, scheduled for next April 7th, constitutes the next major event for investors.
Emeis Stock Regains Momentum After Unfavorable Weekly Sequence
Emeis stock has regained momentum after a challenging week: over the past seven days, the stock still showed a decline of 3.37%. Today's rise brings the share above its 50-day moving average, located at 14.27 euros, a threshold it had recently breached. This upward crossing is a technical signal generally interpreted as a return of positive short-term momentum. The RSI, an indicator measuring the speed of price movements, stands at 42, indicating a still moderate level that reflects the absence of overheating in buying. The stock also moves within a channel defined by a support at 13.55 euros and a resistance at 15.49 euros. Over three months, the performance remains positive at 3.62%, while over a year, the gain reaches 19.42%, demonstrating a medium-term upward trajectory despite recent fluctuations.
Next Catalyst Identified for the Stock: Publication of 2025 Annual Results
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The next identified catalyst for the stock lies in the publication of the annual 2025 results, scheduled for April 7th. This event will be closely monitored to assess the operational and financial trajectory of the group, formerly known as Orpea, in its ongoing restructuring. However, the market environment continues to be marked by tensions. The VIX, the American market volatility index, was at 29.49 points in its last reading on March 6th, up sharply by 24.17% from the previous day, a level indicating increased nervousness in global markets. The very low beta of the stock (0.10) indicates, however, a limited correlation with general market fluctuations, which tends to partially isolate Emeis from overall movements. The monthly volatility of the stock stands at 17.97%, a level that remains contained given the global context.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.